Clint Flanagan
Family Medicine · Dacono, CONPI 1568467983
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Exact Sciences at 35.9% of the total. 2025 is the largest year on record at $53, 4.0 times the $13 reported in 2020. That places this record below the midpoint for family medicine clinicians in CO, where the typical reported total is $136.
Across 8 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$53
- AbbVie$48
- Merz North America, Inc.$35
- Pfizer$12
Across 2,835 payments — averaging $2689.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$6.4M
- Pfizer$917K
- Seqirus USA Inc$194K
- GSK$47K
- Biohaven Pharmaceutical Holding Company Ltd.$22K
- AstraZeneca$18K
- plus $16K from 1 others
What the payments were for
- Food & beverage$148100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 3 | $53 |
| AbbVie | 3 | $48 |
| Merz North America, Inc. | 1 | $35 |
| Pfizer | 1 | $12 |
How this compares
$148 in reported general payments places this provider in the 50th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Combivent RespimatIpratropium/Albuterol Sulfate | 16 | $7,903 |
| Levothyroxine Sodium | 28 | $400 |
| Rosuvastatin Calcium | 35 | $360 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 11 | $228 |
| Tramadol Hcl | 23 | $222 |
| Metformin Hcl | 15 | $188 |
| Lisinopril | 15 | $174 |
| Gabapentin | 25 | $167 |
| Losartan Potassium | 16 | $160 |
| Amlodipine Besylate | 22 | $149 |
| Atorvastatin Calcium | 12 | $95 |
| Alprazolam | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Dacono
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Matthew YoungColorado Springs$270K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
- Michael MeekerUsaf Academy$174K
- Carolynn Francavilla BrownLakewood$174K
- Lawrence AndrewsColorado Springs$102K
- Gregory MaederWestminster$95K
- Paul SimmonsGrand Junction$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.